Revelation Biosciences (REVB) Reports Q3 Loss of $0.42

Revelation Biosciences (NASDAQ: REVB) reported Q3 EPS of ($0.42).

For earnings history and earnings-related data on Revelation Biosciences (REVB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• SanDisk upgraded at JPMorgan after investor day; shares climb